Frequently Asked Questions about Bioqual, Inc. (BIOQ)

Name: Bioqual, Inc. (BIOQ) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Bioqual, Inc. (BIOQ) do?

Accepted Answer

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis...

Question 2

Is Bioqual, Inc. (BIOQ) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of BIOQ reveals an Altman Z-Score of 2.11 and a Piotroski F-Score of 6/9. These metrics, combined with its 5-year revenue trend ($0.05B most recent), help investors decide if BIOQ fits their risk profile.

Question 3

What is the current P/E ratio for BIOQ?

Accepted Answer

As of the latest trading session, Bioqual, Inc. (BIOQ) has a trailing P/E ratio of 74.02.

Question 4

Who is the CEO of Bioqual, Inc.?

Accepted Answer

The current Chief Executive Officer of Bioqual, Inc. is Hanne Andersen-Elyard.

Question 5

What was BIOQ's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Bioqual, Inc. reported annual revenues of $0.05B (2025), $0.06B (2024), $0.06B (2023), $0.07B (2022), $0.06B (2021) respectively.

Question 6

Does BIOQ pay a dividend?

Accepted Answer

Bioqual, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does BIOQ have?

Accepted Answer

In its latest reporting period, Bioqual, Inc. generated $0.00B in Free Cash Flow against a total debt load of $0.02B.

Question 8

What is the Price-to-Book (P/B) ratio of Bioqual, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Bioqual, Inc. (BIOQ) is currently 0.94.

Question 9

What is the Price-to-Sales (P/S) ratio of BIOQ?

Accepted Answer

Based on trailing twelve-month data, Bioqual, Inc. (BIOQ) trades at a Price-to-Sales (P/S) ratio of 0.72.

Question 10

What is Bioqual, Inc.'s Return on Equity (ROE)?

Accepted Answer

Bioqual, Inc. (BIOQ) has a Return on Equity (ROE) of 1.26%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-05	2.9M	0	-238.8K	2.7M	2.7M
2024-05	9.4M	0	-597.1K	8.8M	8.8M
2023-05	8.2M	0	-2.2M	6M	6M
2022-05	313.4K	0	-4.9M	-4.6M	-4.6M
2021-05	2.1M	4.8K	-4.4M	-2.3M	-2.3M

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2025-05	2.9M	0	-238.8K	2.7M	2.7M
2024-05	9.4M	0	-597.1K	8.8M	8.8M
2023-05	8.2M	0	-2.2M	6M	6M
2022-05	313.4K	0	-4.9M	-4.6M	-4.6M
2021-05	2.1M	4.8K	-4.4M	-2.3M	-2.3M